[1]
|
Ma, X.M. and Blenis, J. (2009) Molecular Mechanisms of mTOR-Mediated Translational Control. Nature Reviews Mo-lecular Cell Biology, 10, 307-318. https://doi.org/10.1038/nrm2672
|
[2]
|
Gui, C.P., Liao, B., Luo, C.G., Chen, Y.H., Tan, L., Tang, Y.M., Li, J.Y., Hou, Y., Song, H.D., Lin, H.S., Xu, Q.H., Yao, G.S., Yao, H.H., Xi-Liu, Luo, J.H., Cao, J.Z. and Wei, J.H. (2021) circCHST15 Is a Novel Prognostic Biomarker That Promotes Clear Cell Renal Cell Car-cinoma Cell Proliferation and Metastasis through the miR-125a-5p/EIF4EBP1 Axis. Molecular cancer, 20, Article No. 169. https://doi.org/10.1186/s12943-021-01449-w
|
[3]
|
Vishnoi, K., Ke, R., Saini, K.S., Viswakarma, N., Nair, R.S., Das, S., Chen, Z., Rana, A. and Rana, B. (2021) Berberine Represses β-Catenin Translation Involving 4E-BPs in Hepatocellular Carcinoma Cells. Molecular Pharmacology, 99, 1-16. https://doi.org/10.1124/molpharm.120.000029
|
[4]
|
Alabdullah, M.L., Ahmad, D.A., Moseley, P., Madhusudan, S., Chan, S. and Rakha, E. (2019) The mTOR Downstream Regulator (p-4EBP1) Is a Novel Independent Prognostic Marker in Ovarian Cancer. Journal of Obstetrics and Gynaecology: The Journal of the Institute of Obstetrics and Gynaecology, 39, 522-528.
https://doi.org/10.1080/01443615.2018.1534091
|
[5]
|
Xu, X., Kong, X., Liu, T., Zhou, L., Wu, J., Fu, J., Wang, Y., Zhu, M., Yao, S., Ding, Y., Ding, L., Li, R., Zhu, X., Tang, X., Zhang, Y., Yang, Q., Ling, J. and Zhou, H. (2019) Me-tastasis-Associated Protein 1, Modulated by miR-30c, Promotes Endometrial Cancer Progression through AKT/mTOR/4E-BP1 Pathway. Gynecologic Oncology, 154, 207-217. https://doi.org/10.1016/j.ygyno.2019.04.005
|
[6]
|
Tian, B., Liu, J., Zhang, N., Song, Y., Xu, Y., Xie, M., Wang, B., Hua, H., Shen, Y., Li, Y. and Yang, M. (2021) Oncogenic SNORD12B Activates the AKT-mTOR-4EBP1 Signaling in Esophageal Squamous Cell Carcinoma via Nucleus Partitioning of PP-1α. Oncogene, 40, 3734-3747. https://doi.org/10.1038/s41388-021-01809-2
|
[7]
|
Tameire, F., Verginadis, I.I., Leli, N.M., Polte, C., Conn, C.S., Ojha, R., Salas Salinas, C., Chinga, F., Monroy, A.M., Fu, W., Wang, P., Kossenkov, A., Ye, J., Amaravadi, R.K., Ig-natova, Z., Fuchs, S.Y., Diehl, J.A., Ruggero, D. andKoumenis, C. (2019) ATF4 Couples MYC-Dependent Translation-al Activity to Bioenergetic Demands during Tumour Progression. Nature Cell Biology, 21, 889-899. https://doi.org/10.1038/s41556-019-0347-9
|
[8]
|
El Guerrab, A., Bamdad, M., Bignon, Y.J., Penault-Llorca, F. and Aubel, C. (2020) Co-Targeting EGFR and mTOR with Gefitinib and Everolimus in Triple-Negative Breast Cancer Cells. Scientific Reports, 10, Article No. 6367.
https://doi.org/10.1038/s41598-020-63310-2
|
[9]
|
Ozdemir Kutbay, N., Biray Avci, C., SarerYurekli, B., Caliskan Kurt, C., Shademan, B., Gunduz, C. and Erdogan, M. (2020) Effects of Metformin and Pioglitazone Combination on Apoptosis and AMPK/mTOR Signaling Pathway in Human Anaplastic Thyroid Cancer Cells. Journal of Biochemical and Molecular Toxicology, 34, e22547.
https://doi.org/10.1002/jbt.22547
|
[10]
|
Wu, Q., Ma, J., Wei, J., Meng, W., Wang, Y. and Shi, M. (2021) FOXD1-AS1 Regulates FOXD1 Translation and Promotes Gastric Cancer Progression and Chemoresistance by Acti-vating the PI3K/AKT/mTOR Pathway. Molecular Oncology, 15, 299-316. https://doi.org/10.1002/1878-0261.12728
|
[11]
|
Wu, Z.R., Yan, L., Liu, Y.T., Cao, L., Guo, Y.H., Zhang, Y., Yao, H., Cai, L., Shang, H.B., Rui, W.W., Yang, G., Zhang, X.B., Tang, H., Wang, Y., Huang, J.Y., Wei, Y.X., Zhao, W.G., Su, B. and Wu, Z.B. (2018) Inhibition of mTORC1 by lncRNA H19 via Disrupting 4E-BP1/Raptor Interaction in Pitui-tary Tumours. Nature Communications, 9, Article No. 4624. https://doi.org/10.1038/s41467-018-06853-3
|
[12]
|
Spirina, L.V., Avgustinovich, A.V., Afanas’ev, S.G., Kondako-va, I.V., Volkov, M.Y., Dobrodeev, A.Y. and Boronkina, A. I. (2020) AKT/mTOR Signal Cascade and Expression of PD-1, PD-L1, and PD-L2 in Gastric Cancer. Bulletin of Experimental Biology and Medicine, 170, 75-78. https://doi.org/10.1007/s10517-020-05007-0
|
[13]
|
Chen, R., Malagola, E., Dietrich, M., Zuellig, R., Tschopp, O., Bombardo, M., Saponara, E., Reding, T., Myers, S., Hills, A.P., Graf, R. and Sonda, S. (2020) Akt1 Signalling Supports Acinar Proliferation and Limits Acinar-to-Ductal Metaplasia Formation upon Induction of Acute Pancreatitis. The Jour-nal of Pathology, 250, 42-54.
https://doi.org/10.1002/path.5348
|
[14]
|
Wang, Z., Li, J., Zhang, P., Zhao, L., Huang, B., Xu, Y., Wu, G. and Xia, Q. (2022) The Role of ERBB Signaling Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma and Establishing a Prognostic Risk Assessment Model for Patients. Frontiers in Genetics, 13, 862210. https://doi.org/10.3389/fgene.2022.862210
|
[15]
|
Park, S.A., Kim, L.K., Kim, Y.T., Heo, T.H. and Kim, H.J. (2020) Long Non-Coding RNA Steroid Receptor Activator Promotes the Progression of Endometrial Cancer via Wnt/β-Catenin Signaling Pathway. International Journal of Biological Sciences, 16, 99-115. https://doi.org/10.7150/ijbs.35643
|
[16]
|
Wan, B., Liu, B., Yu, G., Huang, Y. and Lv, C. (2019) Differentially Ex-pressed Autophagy-Related Genes Are Potential Prognostic and Diagnostic Biomarkers in Clear-Cell Renal Cell Carci-noma. Aging, 11, 9025-9042.
https://doi.org/10.18632/aging.102368
|
[17]
|
Wen, Y., Wang, Y., Chelariu-Raicu, A., Stur, E., Liu, Y., Corvigno, S., Bartsch, F., Redfern, L., Zand, B., Kang, Y., Liu, J., Baggerly, K. and Sood, A. K. (2020) Blockade of the Short Form of Prolactin Receptor Induces FOXO3a/EIF- 4EBP1-Mediated Cell Death in Uterine Cancer. Molecular Cancer Therapeu-tics, 19, 1943-1954.
https://doi.org/10.1158/1535-7163.MCT-19-1026
|
[18]
|
Ye, Q., Zhang, Y., Cao, Y., Wang, X., Guo, Y., Chen, J., Horn, J., Ponomareva, L.V., Chaiswing, L., Shaaban, K.A., Wei, Q., Anderson, B.D., St Clair, D.K., Zhu, H., Leggas, M., Thorson, J.S. and She, Q.B. (2019) Frenolicin B Targets Peroxiredoxin 1 and Glutaredoxin 3 to Trigger ROS/4E-BP1-Mediated Antitumor Effects. Cell Chemical Biology, 26, 366-377.e12. https://doi.org/10.1016/j.chembiol.2018.11.013
|